vs

Side-by-side financial comparison of ASTRAZENECA PLC (AZN) and Lennar (LEN). Click either name above to swap in a different company.

ASTRAZENECA PLC is the larger business by last-quarter revenue ($14.5B vs $9.4B, roughly 1.5× Lennar). ASTRAZENECA PLC runs the higher net margin — 16.9% vs 5.2%, a 11.7% gap on every dollar of revenue. On growth, ASTRAZENECA PLC posted the faster year-over-year revenue change (11.7% vs -5.8%).

AstraZeneca plc (AZ) is a Swedish-British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, UK. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.

Lennar Corporation is an American home construction company based in Miami-Dade County, Florida. As of 2025, it is the second-largest home construction company in the United States based on the number of homes sold. Lennar has investments in multifamily and single-family residential rental properties, luxury development, property technology with LenX, and mortgage lending from Lennar Mortgage.

AZN vs LEN — Head-to-Head

Bigger by revenue
AZN
AZN
1.5× larger
AZN
$14.5B
$9.4B
LEN
Growing faster (revenue YoY)
AZN
AZN
+17.6% gap
AZN
11.7%
-5.8%
LEN
Higher net margin
AZN
AZN
11.7% more per $
AZN
16.9%
5.2%
LEN

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
AZN
AZN
LEN
LEN
Revenue
$14.5B
$9.4B
Net Profit
$2.4B
$490.2M
Gross Margin
82.9%
Operating Margin
24.3%
7.3%
Net Margin
16.9%
5.2%
Revenue YoY
11.7%
-5.8%
Net Profit YoY
27.0%
-55.3%
EPS (diluted)
$1.57

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AZN
AZN
LEN
LEN
Q4 25
$9.4B
Q3 25
$8.8B
Q2 25
$14.5B
$8.4B
Q1 25
$7.6B
Q4 24
$9.9B
Q3 24
$9.4B
Q2 24
$12.9B
$8.8B
Q1 24
$7.3B
Net Profit
AZN
AZN
LEN
LEN
Q4 25
$490.2M
Q3 25
$591.0M
Q2 25
$2.4B
$477.4M
Q1 25
$519.5M
Q4 24
$1.1B
Q3 24
$1.2B
Q2 24
$1.9B
$954.3M
Q1 24
$719.3M
Gross Margin
AZN
AZN
LEN
LEN
Q4 25
Q3 25
Q2 25
82.9%
Q1 25
Q4 24
Q3 24
Q2 24
83.1%
Q1 24
Operating Margin
AZN
AZN
LEN
LEN
Q4 25
7.3%
Q3 25
9.0%
Q2 25
24.3%
7.7%
Q1 25
9.1%
Q4 24
14.7%
Q3 24
16.3%
Q2 24
21.2%
14.4%
Q1 24
12.7%
Net Margin
AZN
AZN
LEN
LEN
Q4 25
5.2%
Q3 25
6.7%
Q2 25
16.9%
5.7%
Q1 25
6.8%
Q4 24
11.0%
Q3 24
12.3%
Q2 24
14.9%
10.9%
Q1 24
9.8%
EPS (diluted)
AZN
AZN
LEN
LEN
Q4 25
Q3 25
$2.29
Q2 25
$1.57
$1.81
Q1 25
$1.96
Q4 24
$4.03
Q3 24
$4.26
Q2 24
$1.24
$3.45
Q1 24
$2.57

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AZN
AZN
LEN
LEN
Cash + ST InvestmentsLiquidity on hand
$7.1B
$3.8B
Total DebtLower is stronger
$5.9B
Stockholders' EquityBook value
$44.8B
$22.0B
Total Assets
$112.4B
$34.4B
Debt / EquityLower = less leverage
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AZN
AZN
LEN
LEN
Q4 25
$3.8B
Q3 25
Q2 25
$7.1B
Q1 25
Q4 24
$4.9B
Q3 24
Q2 24
$6.9B
Q1 24
Total Debt
AZN
AZN
LEN
LEN
Q4 25
$5.9B
Q3 25
Q2 25
Q1 25
Q4 24
$4.2B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
AZN
AZN
LEN
LEN
Q4 25
$22.0B
Q3 25
$22.6B
Q2 25
$44.8B
$22.6B
Q1 25
$22.7B
Q4 24
$27.9B
Q3 24
$27.4B
Q2 24
$39.6B
$26.9B
Q1 24
$26.6B
Total Assets
AZN
AZN
LEN
LEN
Q4 25
$34.4B
Q3 25
$34.9B
Q2 25
$112.4B
$34.4B
Q1 25
$35.0B
Q4 24
$41.3B
Q3 24
$39.7B
Q2 24
$104.3B
$38.7B
Q1 24
$39.0B
Debt / Equity
AZN
AZN
LEN
LEN
Q4 25
0.27×
Q3 25
Q2 25
Q1 25
Q4 24
0.15×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AZN
AZN
LEN
LEN
Operating Cash FlowLast quarter
$1.8B
Free Cash FlowOCF − Capex
$1.7B
FCF MarginFCF / Revenue
17.9%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
3.59×
TTM Free Cash FlowTrailing 4 quarters
$28.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AZN
AZN
LEN
LEN
Q4 25
$1.8B
Q3 25
$-158.6M
Q2 25
$-1.1B
Q1 25
$-289.0M
Q4 24
$974.5M
Q3 24
$819.2M
Q2 24
$241.8M
Q1 24
$367.9M
Free Cash Flow
AZN
AZN
LEN
LEN
Q4 25
$1.7B
Q3 25
$-190.8M
Q2 25
$-1.1B
Q1 25
$-345.1M
Q4 24
$933.1M
Q3 24
$800.8M
Q2 24
$203.0M
Q1 24
$294.9M
FCF Margin
AZN
AZN
LEN
LEN
Q4 25
17.9%
Q3 25
-2.2%
Q2 25
-13.3%
Q1 25
-4.5%
Q4 24
9.4%
Q3 24
8.5%
Q2 24
2.3%
Q1 24
4.0%
Capex Intensity
AZN
AZN
LEN
LEN
Q4 25
0.9%
Q3 25
0.4%
Q2 25
0.2%
Q1 25
0.7%
Q4 24
0.4%
Q3 24
0.2%
Q2 24
0.4%
Q1 24
1.0%
Cash Conversion
AZN
AZN
LEN
LEN
Q4 25
3.59×
Q3 25
-0.27×
Q2 25
-2.29×
Q1 25
-0.56×
Q4 24
0.89×
Q3 24
0.70×
Q2 24
0.25×
Q1 24
0.51×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AZN
AZN

Segment breakdown not available.

LEN
LEN

Lennar Homebuilding East Central West Houstonand Other$8.9B95%
Lennar Financial Services$308.8M3%
Lennar Multifamily$158.7M2%
Lennar Other$14.8M0%
Homebuilding Other Regions$3.9M0%

Related Comparisons